Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
ACCELERON PHARMA INC (XLRN)
Sector: Healthcare; Industry: Biotechnology

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its therapeutic candidates include luspatercept, which completed Phase III clinical trials for the treatment of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis; Phase II clinical trials for the treatment of patients with transfusion-dependent beta-thalassemia. It has a collaboration, license, and option agreement with Celgene Corporation; and collaboration and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-05 Zakrzewski Joseph S Director Sell 10,000 $140.73 $1,407,343 Yes
2021-04-05 Smith Karen L. Director Sell 11,864 $140.19 $1,663,156 Yes
2021-04-01 Zakrzewski Joseph S Director Sell 10,000 $134.64 $1,346,382 Yes
2021-04-01 Smith Karen L. Director Sell 8,925 $136.47 $1,218,003 Yes
2021-03-02 KANGO SUJAY EVP, Chief Commercial Officer Sell 5,000 $136.01 $680,059 Yes
2021-01-05 Veness Adam M SVP, General Counsel and Sec. Sell 2,056 $122.56 $251,988 No
2021-01-04 KANGO SUJAY EVP, Chief Commercial Officer Sell 10,000 $125.38 $1,253,759 No
2021-01-05 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 4,779 $123.24 $588,974 No
2021-01-05 Dable Habib J CEO and President Sell 4,258 $121.13 $515,774 No
2020-12-14 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 42,528 $130.14 $5,534,594 Yes
2020-12-11 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 7,472 $125.02 $934,176 Yes
2020-10-12 Kearney Terrence C Director Sell 37,500 $119.36 $4,475,981 Yes
2020-09-11 MCCOURT Thomas A Director Sell 23,272 $90.39 $2,103,466 Yes
2020-09-08 Veness Adam M SVP, General Counsel and Sec. Sell 2,000 $89.50 $179,004 No
2020-07-09 CELGENE CORP /DE/ 10%-Owner Sell 2,241 $102.28 $229,209 Yes
2020-07-01 Dable Habib J CEO and President Sell 50,000 $96.41 $4,820,445 Yes
2020-07-01 CELGENE CORP /DE/ 10%-Owner Buy 108,108 $92.50 $9,999,990 No
2020-04-08 Veness Adam M SVP, General Counsel and Sec. Sell 6,000 $85.58 $513,509 Yes
2020-04-09 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 54,000 $86.37 $4,663,775 Yes
2020-02-13 KANGO SUJAY EVP, Chief Commercial Officer Sell 595 $94.10 $55,987 No
2020-01-03 Veness Adam M VP, General Counsel and Sec. Sell 1,309 $51.76 $67,754 No
2020-01-03 KANGO SUJAY SVP, Chief Commercial Officer Sell 480 $51.37 $24,656 No
2020-01-02 Quisel John D EVP, Chief Business Officer Sell 5,842 $52.52 $306,806 No
2020-01-02 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 5,579 $52.50 $292,923 No
2020-01-03 Dable Habib J CEO and President Sell 3,732 $51.24 $191,230 No
2019-12-13 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 11,853 $50.28 $595,969 No
2019-09-10 Veness Adam M VP, General Counsel and Sec. Sell 824 $45.20 $37,241 No
2019-09-10 Kumar Ravindra SVP & Chief Scientific Officer Sell 3,389 $45.24 $153,318 No
2019-09-10 Quisel John D EVP, Chief Business Officer Sell 3,584 $45.23 $162,104 No
2019-09-10 MCLAUGHLIN KEVIN F SVP, CFO and Treasurer Sell 8,000 $45.30 $362,400 No

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.